Fusion Pharmaceuticals Inc logo

FUSN - Fusion Pharmaceuticals Inc News Story

$8.56 0.0  0.0%

Last Trade - 21/09/21

Sector
Healthcare
Size
Small Cap
Market Cap £269.6m
Enterprise Value £138.9m
Revenue £381k
Position in Universe 4085th / 7157

BUZZ-Fusion Pharma surges after encouraging early data from cancer therapy

Tue 15th June, 2021 12:40pm
** Biotech company's shares  FUSN.O  jump about 11% to $9.04
premarket, set for their best day ever since listing in June
2020
    ** Early-stage data shows Fusion's lead alpha therapy
candidate, FPI-1434, for targeted tumor cells shows favorable
safety profile with no drug-related serious adverse at three
different dose levels  urn:newsml:reuters.com:*:nPnbLfJdva
    ** Co also says early data for FPI-1434 in combination with
another cancer therapy olaparib indicated efficacy against
colorectal and lung cancer tumor models 
    ** In November, co announced a tie up with AstraZeneca PLC
 AZN.L  to develop and sell combination therapies for cancer
 urn:newsml:reuters.com:*:nL4N2HO31A
    ** FUSN down about 30% this year

 (Reporting by Medha Singh in Bengaluru)
 ((medha.singh@thomsonreuters.com))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.